MedTrace Logo

Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS)

NCT06040476 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2025-02-27

No results posted yet for this study

Summary

A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke

Conditions

  • Acute Ischemic Stroke

Interventions

BIOLOGICAL

hUCB

hUCB

Sponsors & Collaborators

  • StemCyte Taiwan Co., Ltd.

    collaborator INDUSTRY

  • StemCyte, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2027-12-31
Completion
2028-08-31
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06040476 on ClinicalTrials.gov